Modified BuShenYiQi formula alleviates experimental allergic asthma in mice

negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP–VPAC2 signalling pathway

★ 5.0 · 98 reads

Sign in to save this
Request Code
ZLIB.IO18502490
Published
2022
Pages
1
Language
Unknown